 | | PRD_002349 | | Name: | ~{N}-[(2~{S})-3-(3-fluorophenyl)-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]propan-2-yl]-1~{H}-indole-2-carboxamide | | Formula: | C25 H25 F N4 O4 | | Definition date: | 2020-06-03 | | Last modified: | 2020-06-03 |
|
 | | PRD_002385 | | Name: | Papain-like protease peptide inhibitor VIR250 | | Formula: | C23 H32 N6 O6 S | | Definition date: | 2020-05-20 | | Last modified: | 2020-05-20 |
|
 | | PRD_002382 | | Name: | boceprevir (bound form) | | Formula: | C27 H47 N5 O5 | | Definition date: | 2020-05-06 | | Last modified: | 2020-05-06 |
|
 | | PRD_001136 | | Name: | SUGAR (6-MER) | | Formula: | C57 H82 O26 | | Description: | Chromomycin A3 is an anthraquinone. It is a glycosidic antibiotic produced at the fermentation of a strain of Streptomyces griseus. It is also called toyomycin. | | Definition date: | 2013-07-26 | | Last modified: | 2020-04-04 |
|
 | | PRD_002326 | | Name: | Phosphinic inhibitor DG014 | | Formula: | C62 H91 N9 O18 P | | Definition date: | 2019-12-18 | | Last modified: | 2019-12-18 |
|
 | | PRD_002357 | | Name: | SHV-WFP-SER-PRO-YCP-ALA-MP8 Acyldepsipeptide | | Formula: | C39 H54 F2 N6 O8 | | Definition date: | 2019-11-06 | | Last modified: | 2019-11-06 |
|
 | | PRD_002359 | | Name: | OO1-WFP-SER-PRO-YCP-ALA-MP8 ureadepsipeptide | | Formula: | C40 H49 F2 N7 O8 | | Definition date: | 2019-11-06 | | Last modified: | 2019-11-06 |
|
 | | PRD_002368 | | Name: | cyclo-Mle-Phe-Mle-D-Phe. D-Phe analogue of pseudoxylallemycin A | | Formula: | C32 H44 N4 O4 | | Definition date: | 2019-10-02 | | Last modified: | 2019-10-02 |
|
 | | PRD_002333 | | Name: | Pseudoxylallemycin A | | Formula: | C32 H44 N4 O4 | | Definition date: | 2019-09-11 | | Last modified: | 2019-09-11 |
|
 | | PRD_002334 | | Name: | Linear tetrapeptide related to pseudoxylallemycin A | | Formula: | C32 H46 N4 O5 | | Definition date: | 2019-09-11 | | Last modified: | 2019-09-11 |
|
 | | PRD_002335 | | Name: | Linear precursor of pseudoxylallemycin A | | Formula: | C32 H46 N4 O5 | | Description: | Mle-Phe-Mle-Phe. Linear precursor of pseudoxylallemycin A. The peptide is linear, unlike Mle-Phe-Mle-Phe Pseudoxylallemycin A that is cyclic. | | Definition date: | 2019-09-11 | | Last modified: | 2019-09-11 |
|
 | | PRD_001037 | | Name: | N~2~-[(2R,5S)-5-({(2S,3S)-2-[(N-acetyl-L-threonyl)amino]-3-methylpent-4-enoyl}amino)-2-butyl-4,4-dihydroxynonanoyl]-L-glutaminyl-L-argininamide | | Formula: | C36 H68 N10 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2019-07-25 |
|
 | | PRD_002355 | | Name: | Microcin C | | Formula: | C38 H63 N17 O17 P S | | Definition date: | 2019-07-10 | | Last modified: | 2019-07-10 |
|
 | | PRD_002306 | | Name: | (2S,5R,8S,11S,14R,17S,20S,22R,23S)-5-[(2E)-but-2-en-1-yl]-23-hydroxy-8-({1-[(3R)-3-hydroxy-2-methylbutan-2-yl]-1H-indol-3-yl}methyl)-14-[(4-hydroxy-3-nitrophenyl)methyl]-10,17,19,22-tetramethyl-2,11-bis(2-methylpropyl)-1,4,7,10,13,16,19-heptaazabicyclo[18.3.1]tetracosane-3,6,9,12,15,18,24-heptone | | Formula: | C54 H77 N9 O12 | | Definition date: | 2019-06-04 | | Last modified: | 2019-06-04 |
|
 | | PRD_002311 | | Name: | ACE-MVA-MP8-NZC-LEU-MP8-LEU-MVA-PRO-MLU-GLY | | Formula: | C57 H96 N10 O12 | | Definition date: | 2019-05-29 | | Last modified: | 2019-05-29 |
|
 | | PRD_002312 | | Name: | (GZJ)VDINNN(CY3) Cyclic peptide inhibitor | | Formula: | C36 H58 N12 O14 S | | Definition date: | 2019-04-17 | | Last modified: | 2019-04-17 |
|
 | | PRD_002313 | | Name: | WDINNN(BAL) Cyclic peptide inhibitor | | Formula: | C36 H49 N11 O12 | | Definition date: | 2019-04-17 | | Last modified: | 2019-04-17 |
|
 | | PRD_002319 | | Name: | (6D6)PPKRIA(NH2), DC100-1 | | Formula: | C48 H84 N18 O11 | | Definition date: | 2019-04-03 | | Last modified: | 2019-04-03 |
|
 | | PRD_002316 | | Name: | Apollo peptide | | Formula: | C46 H68 N8 O7 | | Definition date: | 2019-02-13 | | Last modified: | 2019-02-13 |
|
 | | PRD_002284 | | Formula: | C37 H57 N11 O11 | | Definition date: | 2018-11-07 | | Last modified: | 2018-11-07 |
|
 | | PRD_002328 | | Name: | TYROSTATIN (Bound Form) | | Formula: | C29 H41 N3 O6 | | Definition date: | 2018-10-24 | | Last modified: | 2018-10-31 |
|
 | | PRD_002327 | | Name: | PSEUDOTYROSTATIN (Bound Form) | | Formula: | C23 H30 N2 O5 | | Definition date: | 2018-10-24 | | Last modified: | 2018-10-24 |
|
 | | PRD_002331 | | Name: | Chymostatin A (bound form) | | Formula: | C31 H43 N7 O6 | | Definition date: | 2018-10-24 | | Last modified: | 2018-10-24 |
|
 | | PRD_002298 | | Name: | N2-[4-(carbamimidamidomethyl)phenyl]acetyl-D-lysyl-L-lysyl-D-arginine | | Formula: | C28 H51 N11 O5 | | Definition date: | 2018-10-17 | | Last modified: | 2018-10-17 |
|
 | | PRD_002304 | | Name: | N2-{[4-(carbamimidamidomethyl)phenyl]acetyl}-L-arginyl-L-arginyl-N-[(4-carbamimidoylphenyl)methyl]-L-argininamide | | Formula: | C36 H61 N18 O4 | | Definition date: | 2018-10-17 | | Last modified: | 2018-10-17 |
|
